Skip to main content

Healthcare Analytical Testing Services Market to Surpass Valuation of USD 15.55 Billion by 2031 | SkyQuest Technology

The healthcare analytical testing services market is growing due to rising clinical trials, biosimilar focus, increased outsourcing, and the impact of COVID-19.

Westford, USA, Dec. 15, 2024 (GLOBE NEWSWIRE) — SkyQuest projects that the global healthcare analytical testing services market size will reach a value of USD 15.55 Billion by 2031, with a CAGR of 11.2% during the forecast period (2024-2031). The market’s main driving factors are the number of companies in the pharmaceutical and medical device industries that outsource analytical testing services, increased clinical trials in need of analytical testing, and the rising emphasis on biosimilars. The industry has grown as a result of the COVID-19 pandemic. Additionally, since the pandemic, the market has seen a quick development in medications and treatments for its prevention, which has increased the demand for analytical testing services. 

Browse in-depth TOC on the “Healthcare Analytical Testing Services Market” 

Pages – 168

Tables – 61

Figures – 70

To Learn More About This Report, Request a Free Sample Copyhttps://www.skyquestt.com/sample-request/healthcare-analytical-testing-services-market

Healthcare Analytical Testing Services Market Overview: 

Report Coverage  Details  
Market Revenue in 2023  USD 7.39 Billion 
Estimated Value by 2031 USD 15.55 Billion 
Growth Rate  Poised to grow at a CAGR of 11.2% 
Forecast Period  2024–2031 
Forecast Units  Value (USD Billion) 
Report Coverage  Type, End User, and Trends 
Segments Covered  Type, Gender, Service, Application, and Region 
Geographies Covered  North America, Europe, Asia Pacific, Middle East & Africa, Latin America 
Report Highlights  Outsourcing of analytical testing services 
Key Market Opportunities  Adoption of digital technology 
Key Market Drivers Increasing demand for medical testing services 

Pharmaceutical Analytical Testing Services to Hold Significant Growth due to Increasing Regulatory Requirements 

The dominance of pharmaceutical analytical testing services in the global healthcare analytical testing services market is driven by increasing regulatory requirements, the rising complexity of drug formulations, and the demand for quality assurance. Those services provide strict compliance, improved drug safety, and support an increasing demand for accurate reliable testing in the pharmaceutical industry, reflecting a promising global healthcare analytical testing services market outlook. 

Make an Inquiry to Address your Specific Business Needs: https://www.skyquestt.com/speak-with-analyst/healthcare-analytical-testing-services-market

Pharmaceutical & Biopharmaceutical Companies to Lead Market due to Increasing Demand for Drug Development 

Pharmaceutical and biopharmaceutical companies dominate the global healthcare analytical testing services market due to the increasing demand for drug development and manufacturing. This calls for a specific analytical service meant for ensuring safety, efficacy, and compliance with all world standards along the lines of the production process. It is really meant for stringent regulatory compliance, product quality assurance, and testing the biologics during their production, which supports positive global healthcare analytical testing services market trends. 

Asia Pacific to Dominate Market due to Advanced Technological Capabilities & Stringent Regulatory Frameworks 

North America’s dominance in the global healthcare analytical testing services market is fueled by robust healthcare infrastructure, advanced technological capabilities, and stringent regulatory frameworks. These aspects are the ones driving up a high demand for the proper testing services through which pharmaceutical innovations are done, clinical tests take place, and compliance with regulatory standards is met, securing the place of North America as the leader in the global healthcare analytical testing services market outlook. 

Healthcare Analytical Testing Services Market Insight 

Drivers: 

  1. Reliable Analytical Testing Services to Ensure Compliance 
  2. Growing Complexity of Drug Formulations 
  3. Growth in Biologics and Biosimilars 

Restraints: 

  1. High Cost of Analytical Testing Services 
  2. Achieving Fast Turnaround Times 
  3. Increasing Concerns Around Data Security in Testing Services 

Take Action Now: Secure Your Healthcare Analytical Testing Services Market Todayhttps://www.skyquestt.com/buy-now/healthcare-analytical-testing-services-market

Prominent Players in Healthcare Analytical Testing Services Market 

  • Eurofins Scientific (Luxembourg)
  • Laboratory Corporation of America Holdings (US)
  • SGS S.A. (Switzerland)
  • Charles River Laboratories (US)
  • WuXi AppTec Co. Ltd. (China)
  • Element Materials Technology (UK)
  • Thermo Fisher Scientific, Inc. (US)
  • Pace Analytical Services LLC (US)
  • Intertek Group plc (UK)
  • IQVIA Inc. (US)
  • Merck KGaA (Germany)
  • Source BioScience (UK)
  • Almac Group (UK)
  • ICON Plc (Ireland)
  • Frontage Laboratories, Inc. (US)
  • STERIS Plc (US)
  • Sartorius AG (Germany)
  • ALS Life Science (US)
  • Syneos Health, INC (US)
  • Medpace Holdings, Inc. (US) 

Key Questions Answered in Global Healthcare Analytical Testing Services Market Report 

  • What will be the projected market size of the global healthcare analytical testing services industry by 2031? 
  • What are the primary factors driving the growth of healthcare analytical testing services? 
  • Which region is expected to dominate the market, and what factors contribute to its dominance? 

Read Healthcare Analytical Testing Services Market Report Todayhttps://www.skyquestt.com/report/healthcare-analytical-testing-services-market

This report provides the following insights: 

Analysis of key drivers (Pandemic increased demand for testing services, higher incidences of chronic conditions, emphasis on drug safety & efficacy), restraints (Regulatory delays in approvals, healthcare budget constraints) opportunities (Growth of telemedicine, rise of point-of-care diagnostics) influencing the growth of healthcare analytical testing services market. 

  • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the healthcare analytical testing services market. 
  • Product Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and product launches in the healthcare analytical testing services market. 
  • Market Development: Comprehensive information on lucrative emerging regions 
  • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the market 
  • Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players. 

Related Reports:

Biodefense Market is growing at a CAGR of 5.03% in the forecast period (2024-2031)

Gene Editing Market is growing at a CAGR of 6.80% in the forecast period (2024-2031)

Varicose Veins Treatment Market is growing at a CAGR of 6.32% in the forecast period (2024-2031)

Digital Genome Market is growing at a CAGR of 18.5% in the forecast period (2024-2031)

Membrane Chromatography Market is growing at a CAGR of 14.90% in the forecast period (2024-2031)

About Us: 

SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.  

We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization have expanded our reach across North America, Europe, ASEAN and Asia-Pacific. 

Contact Us: 

Mr. Jagraj Singh 
SkyQuest Technology 
1 Apache Way, 
Westford, 
Massachusetts 01886 
USA (+1) 351-333-4748 
Email: sales@skyquestt.com 
Visit Our Website: https://www.skyquestt.com/ 

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.